AbbVie lung cancer drug data shows high response rates at WCLC 2026

August 21, 2026 7:45 AM

AbbVie (NYSE: ABBV) announced it is presenting clinical data from multiple investigational lung cancer programs at the 2026 World Conference ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found